SCHEMBL13828355

SCHEMBL13828355

CC(=O)c1ccc(-c2nn(C)c3ncnc(N)c23)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.60
PIK3CA P42336 14/20 0.60
PIK3CB P42338 14/20 0.60
PRKDC P78527 14/20 0.60
PIK3CG P48736 13/20 0.60
ABL1 P00519 13/20 0.60
EGFR P00533 13/20 0.60
HCK P08631 13/20 0.60
SRC P12931 13/20 0.60
MTOR P42345 13/20 0.60
EPHB4 P54760 13/20 0.60
KDR P35968 12/20 0.60
PI4KB Q9UBF8 5/20 0.60
RIPK1 Q13546 3/20 0.54
AURKA O14965 1/20 0.52
IKBKE Q14164 1/20 0.52
AURKB Q96GD4 1/20 0.52
EIF2AK3 Q9NZJ5 1/20 0.51
NUDT14 O95848 1/20 0.51
NUDT5 Q9UKK9 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27953700 0.85 PIK3CD (0.50) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL13828434 0.84 RIPK1 (0.65) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130418 0.83 PIK3CD (0.73) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL30320603 0.83 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL21436578 0.83 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130595 0.82 PIK3CD (0.73) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130466 0.81 PIK3CD (0.76) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL130427 0.81 PIK3CD (0.72) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL129595 0.79 PIK3CD (0.62) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG
SCHEMBL23917244 0.79 PIK3CD (0.74) PIK3CDPIK3CAPIK3CBPRKDCPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10322130-B2 Substituted chromenones as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2019-06-18 US disclosed
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2018-04-26 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed
US-9775841-B2 Compounds as modulators of protein kinases RHIZEN PHARMACEUTICALS SA (CH) 2017-10-03 US disclosed
US-20150320752-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS AG (CH) 2015-11-12 US disclosed
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES RHIZEN PHARMACEUTICALS SA (CH) 2012-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150320752-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB PIK3CD 47/4885PIK3CA 88/4885PIK3CB 23/4885
US-20120289496-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB PIK3CD 47/4885PIK3CA 88/4885PIK3CB 23/4885
US-20180110783-A1 NOVEL COMPOUNDS AS MODULATORS OF PROTEIN KINASES PRKCA, PRKCH, PRKCB PIK3CD 47/4885PIK3CA 88/4885PIK3CB 23/4885
US-10322130-B2 Substituted chromenones as modulators of protein kinases MAP3K1, CSNK1A1, MAP3K2 PIK3CD 148/4885PIK3CA 153/4885PIK3CB 181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.